You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibodies, Monoclonal

Showing 7551 - 7575 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Metastatic Cancer Trial in France (cetuximab, fluorouracil, leucovorin calcium)

Completed
  • Colorectal Cancer
  • Metastatic Cancer
  • cetuximab
  • +3 more
  • Bordeaux, France
  • +6 more
May 14, 2011

Nonalcoholic Steatohepatitis Trial in Jerusalem (OKT3)

Completed
  • Nonalcoholic Steatohepatitis
  • Jerusalem, Israel
    Hadassah University Hospital, Liver Unit
Jun 22, 2011

Breast Cancer Trial in New York (biological, drug, procedure)

Completed
  • Breast Cancer
  • trastuzumab
  • +5 more
  • New York, New York
    NYU School of Medicine's Kaplan Comprehensive Cancer Center
Mar 25, 2011

Diffuse Large B Cell Lymphoma Trial in Mexico (Rituximab)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Rituximab
  • Mexico, D.f., Mexico
    INCan
Jan 12, 2011

Metastatic Melanoma Trial in Jerusalem, Tel Hashomer (188Re-PTI-6D2)

Completed
  • Metastatic Melanoma
  • Jerusalem, Israel
  • +1 more
Jul 12, 2011

Arthritis, Juvenile Idiopathic Trial in Worldwide (Double-Blind Adalimumab/Placebo + MTX, Double-Blind Adalimumab/Placebo, OLE

Completed
Has Results
  • Arthritis, Juvenile Idiopathic
  • Double-Blind Adalimumab/Placebo + MTX
  • +3 more
  • Birmingham, Alabama
  • +30 more
Aug 18, 2011

Colorectal Carcinoma Trial in Englishtown (Cetuximab and Radiation Therapy, Surgery and Radiation Therapy)

Withdrawn
  • Colorectal Carcinoma
  • Cetuximab and Radiation Therapy
  • Surgery and Radiation Therapy
  • Englishtown, New Jersey
    Practicing Physician in New Jersey
Jul 19, 2011

Colorectal Cancer Trial in Aarau, Epalinges, Lausanne (biological, drug, procedure, radiation)

Unknown status
  • Colorectal Cancer
  • cetuximab
  • +5 more
  • Aarau, Switzerland
  • +2 more
May 24, 2011

Uveitis Trial (Remicade (infliximab))

Completed
  • Uveitis
  • Remicade (infliximab)
  • (no location specified)
Jul 1, 2011

Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin, Lymphomas: Non-Hodgkin Cutaneous Lymphoma Trial in Stanford (Rituximab,

Completed
  • Lymphoma, Non-Hodgkin
  • +8 more
  • Stanford, California
    Stanford University School of Medicine
May 31, 2011

Osteoarthritis, Knee Trial in Utrecht (PG110, Placebo)

Completed
  • Osteoarthritis, Knee
  • PG110
  • Placebo
  • Utrecht, Netherlands
    Site Ref # / Investigator 51568
Jun 3, 2011

Metastatic Pancreatic Cancer Trial in United States (cetuximab, bevacizumab, gemcitabine)

Terminated
Has Results
  • Metastatic Pancreatic Cancer
  • cetuximab
  • +2 more
  • Jonesboro, Arkansas
  • +15 more
May 19, 2011

NSCLC Trial in United States (Cetuximab, Bevacizumab, Paclitaxel)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Cetuximab
  • +3 more
  • Decatur, Alabama
  • +42 more
May 13, 2011

Type 2 Diabetes, Impaired Glucose Tolerance Trial in Worldwide (Canakinumab 150 mg, Placebo to Canakinumab)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Impaired Glucose Tolerance
  • Canakinumab 150 mg
  • Placebo to Canakinumab
  • Los Angeles, California
  • +51 more
Aug 3, 2011

Breast Cancer Trial in Heraklion (Trastuzumab)

Completed
  • Breast Cancer
  • Heraklion, Crete, Greece
    University Hospital of Crete
Jul 20, 2011

Influenza Trial in Swiftwater (Inactivated Influenza A Vaccine A/H5N1)

Completed
  • Influenza
  • Inactivated Influenza A Vaccine A/H5N1
  • Swiftwater, Pennsylvania
    Sanofi Pasteur
Aug 11, 2011

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • monoclonal antibody A27.15
  • monoclonal antibody E2.3
  • Tucson, Arizona
    Arizona Cancer Center
Mar 12, 2010

Bronchial Asthma Trial in London (Omalizumab, Placebo)

Unknown status
  • Bronchial Asthma
  • London, United Kingdom
  • +1 more
Jan 20, 2011

Lymphoma Trial in Cleveland (filgrastim, rituximab)

Completed
  • Lymphoma
  • filgrastim
  • rituximab
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute
Mar 28, 2011

Metastatic Solid Tumors Trial in Jerusalem (Cell therapy with bispecific antibodies)

Withdrawn
  • Metastatic Solid Tumors
  • Cell therapy with bispecific antibodies
  • Jerusalem, Israel
    Hadassah Medical Organization
Apr 7, 2011

Ulcerative Colitis Trial in Worldwide (adalimumab, )

Completed
Has Results
  • Ulcerative Colitis
  • adalimumab
  • placebo
  • Anaheim, California
  • +107 more
Apr 28, 2011

Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)

Completed
Has Results
  • Melanoma
  • Metastases
  • MDX-010 (anti-CTLA4) monoclonal antibody
  • MDX-1379 (gp100) Melanoma Peptide Vaccine
  • Tucson, Arizona
  • +208 more
Jun 29, 2011

Recurrent Malignant Glioma Trial in Innsbruck, Salzburg (Bevacizumab / Irinotecan)

Unknown status
  • Recurrent Malignant Glioma
  • Bevacizumab / Irinotecan
  • Innsbruck, Austria
  • +1 more
Aug 1, 2011

Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus Trial in Springfield (rituximab)

Completed
  • Opsoclonus-myoclonus Syndrome
  • +3 more
  • Springfield, Illinois
    National Pediatric Myoclonus Center, Department of Neurology, SI
May 6, 2011

The Immune Base of Endometriosis

Withdrawn
  • Endometriosis
    • (no location specified)
    Jun 26, 2011